GLOBAL NUTRACEUTICALS CAMPAIGN TO RAISE FUNDS FOR RESCUE SHELTER FOR CHILD SEXUAL ABUSE SURVIVORS
#HopeNeedsAHome Cypress Minerals and Cepham Inc lead Fundraising Efforts Because Hope Needs…
15below Acquires Airport AI to Build the First Connected Communications Solution for Air Travel
The acquisition strengthens 15below's AI capabilities, extends its reach into the airport…
Pioneering Quantum-Safe Space Systems: Space TS and Synergy Quantum Forge Historic Alliance for a Secure Space Future
NEW DELHI, July 8, 2025 /PRNewswire/ -- In a landmark move to…
Diginex Announces Plans for Eight-for-One Forward Stock Split
July 07, 2025 23:29 ET | Source: Diginex Limited LONDON, July 07,…
Sirtex Medical’s SIR-Spheres Y-90 Resin Microspheres Receive FDA Approval for the Treatment of Unresectable Hepatocellular Carcinoma
Expanded indication makes SIR-Spheres® the first and only radioembolization therapy in the…
GameChange Solar Secures Landmark 1.25 GW Tracker Deal for Abydos II in Egypt
DUBAI, UAE, July 7, 2025 /PRNewswire/ -- GameChange Solar, a leading global…
Fictiv Receives Frost & Sullivan’s 2025 Global Supply Chain for Custom Mechanicals Technology Innovation Leadership Recognition
Recognized for its innovative approach to global supply chain orchestration, delivering customer…
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:…
LENZ Therapeutics and Laboratoires Tha Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada
Exclusive agreement includes over $70 million in upfront and milestone payments to…
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
July 07, 2025 08:00 ET | Source: KALA BIO, Inc. ARLINGTON, Mass.,…
